Actos Bladder Cancer Lawsuit Update

Tuesday, 15 May 2012 12:24

 

Actos Bladder Cancer Lawsuit Update 

By Scott Hardy

 

One of the latest in a string of lawsuits alleging that Actos causes bladder cancer has been moved from state to federal court at Takeda Pharmaceuticals request. This move hasn't affected any pending Actos (pioglitazone) class action lawsuits.

 

The Actos bladder tumor lawsuit moved to federal court was filed by Richard La Carte. Richard states in his Actos lawsuit that the drug caused his bladder cancer which made him suffer "permanent and life threatening injuries." Richard also states in the Actos lawsuit that he has a "lifelong fear of premature death and the need for continued lifelong treatment and medications." Because of the huge number of people with Type II diabetes who use Actos to treat their affliction this may be a common theme in Actos cancer lawsuits. Richard is demanding $4 million in damages and it's interesting to note that his wife is also demanding $1 million in compensatory damages for "loss of consortium." Loss of consortium is a legal term used in lawsuits where the uninjured spouse sues for the loss of a normal marital relationship (a euphemism for sex.) A jury (or judge) can award damages to the uninjured spouse if they're reasonably swayed by the loss of the sexual relationship.

 

The case was moved to federal court at the request of Takeda Pharmaceuticals. Takeda Pharmaceuticals filed the motion because federal courts are granted jurisdiction over lawsuits where the amount of damages alleged exceeds $75,000 and where the plaintiffs are located in different countries or states, or are citizens of different countries. Takeda Pharmaceuticals corporate office is located in a different state than Richard La Carte and his wife.

 

Type II diabetics who are taking Actos are often unaware of the risk of bladder cancer if they take Actos for at least one year. Actos patients need to know what to look out for if they have taken Actos for more than one year as it may  increase the risk of bladder cancer by 40% or more. Symptoms of bladder cancer include tumors which could cause blood in the urine, painful or frequent urination, or straining during urination. In addition, other common symptoms of bladder cancer include fatigue, incontinence, weight loss and bone pain or tenderness. If you are experiencing these symptoms you should see a doctor immediately so bladder cancer or tumors can be ruled out. If you are experiencing these symptoms and are diagnosed with bladder cancer or tumors it is a good idea to speak with an attorney to see if you are a good fit for an Actos class action lawsuit or an Actos personal injury lawsuit. Patients are filing Actos bladder cancer or cardiovascular problem lawsuits because they believe that they should have been warned of the significant risks of taking Actos. Bladder cancer due to Actos can, and allegedly has, lead to death in multiple patients whose families have filed lawsuits against Takeda Pharmaceuticals.

 

There has been no motion to move the Actos bladder cancer lawsuit to the newly established multidistrict litigation (MDL) established in Louisiana though it's likely to happen within the next few months.

 

If you would like more information about filing an Actos class action lawsuit, information about joining the Actos MDL (multidistrict litigation) which may be more beneficial to those filing an Actos lawsuit compared to an Actos class action lawsuit, or would like to file an Actos bladder cancer personal injury lawsuit just go to the Actos Bladder Cancer Class Action Lawsuit Investigation page. You can submit your information, or your loved one's, to Actos lawyers who are actively investigating all claims regarding tumors, heart attacks, congestive heart failure and other problems which may be a severe side effect of taking Actos. Actos attorneys are waiting to talk to you now and consultation is free.

 

Updated May 15th, 2012

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

Last Updated on Thursday, 27 December 2012 11:09